The slip
PARKINSON RECEIPTno. 11119
26 Oct 2026, 19:04 UTCdopamine neurons, braak
predictionKIAA0319L in dopamine neurons tracks Braak Lewy-body stage
registered22861a444e1061b1
discovery-0.43 p=0.243 n=9
replication+0.05 p=0.891 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.43, p 0.243)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT0c59147a050369234c436a79…
follows 02afb9bd9613…
Covered by the on-chain checkpoint of receipt 11130 (2026-10-26 19:19 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 11119: KIAA0319L in dopamine neurons, braak
- power
- full sample +0.01 (p 0.969, n 18), 95% CI -0.46 to +0.47. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.00 (p 0.990, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.03 (p 0.901, n 18). could be the mix.
- skeptic
- leave-one-out range -0.11 to +0.14, sign flips 7; without severely affected donors +0.01 (p 0.969, n 18). fragile.
- cell type
- strongest in oligodendrocytes: -0.67 (p 0.0022, n 18) vs +0.01 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for KIAA0319L in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up KIAA0319L · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.75 p 0.0077 (needs p < 2.0e-4)